- Home
- Publications
- Publication Search
- Publication Details
Title
Antidepressant Drugs Effects on Blood Pressure
Authors
Keywords
-
Journal
Frontiers in Cardiovascular Medicine
Volume 8, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2021-08-03
DOI
10.3389/fcvm.2021.704281
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Dopamine Receptors and the Kidney: An Overview of Health- and Pharmacological-Targeted Implications
- (2021) Alejandro Olivares-Hernández et al. Biomolecules
- The association of antihypertensive use and depressive symptoms in a large older population with hypertension living in Australia and the United States: a cross-sectional study
- (2020) Bruno Agustini et al. JOURNAL OF HUMAN HYPERTENSION
- Depression and cardiovascular disease: Shared molecular mechanisms and clinical implications
- (2020) Mingjing Shao et al. PSYCHIATRY RESEARCH
- Duloxetine and cardiovascular adverse events: A systematic review and meta-analysis
- (2020) Kyounghoon Park et al. JOURNAL OF PSYCHIATRIC RESEARCH
- The affinity and selectivity of α‐adrenoceptor antagonists, antidepressants, and antipsychotics for the human α1A, α1B, and α1D‐adrenoceptors
- (2020) Richard G. W. Proudman et al. Pharmacology Research & Perspectives
- The Cardiovascular Effects of Newer Antidepressants in Older Adults and Those With or At High Risk for Cardiovascular Diseases
- (2020) Lauren M. Behlke et al. CNS DRUGS
- Antihypertensive Drugs and Risk of Depression
- (2020) Lars Vedel Kessing et al. HYPERTENSION
- Hypertension and orthostatic hypotension with venlafaxine treatment in depressed older adults
- (2020) Rafae Wathra et al. JOURNAL OF PSYCHOPHARMACOLOGY
- Venlafaxine ER blocks the norepinephrine transporter in the brain of patients with major depressive disorder: a PET study using [18F]FMeNER-D2
- (2019) Ryosuke Arakawa et al. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY
- Depression and coronary heart disease: 2018 ESC position paper of the working group of coronary pathophysiology and microcirculation developed under the auspices of the ESC Committee for Practice Guidelines
- (2019) Viola Vaccarino et al. EUROPEAN HEART JOURNAL
- Complex cardiac vagal regulation to mental and physiological stress in adolescent major depression
- (2019) Andrea Mestanikova et al. JOURNAL OF AFFECTIVE DISORDERS
- Use of antidepressants and anxiolytics in early pregnancy and the risk of preeclampsia and gestational hypertension: a prospective study
- (2019) Nathalie Bernard et al. BMC Pregnancy and Childbirth
- The effect of treatment response on endothelial function and arterial stiffness in depression. A prospective study
- (2019) Nikolaos Kokras et al. JOURNAL OF AFFECTIVE DISORDERS
- Gender Disparity in the Risk of Hypertension in Subjects With Major Depressive Disorder
- (2019) Wei-Tsung Kao et al. Frontiers in Psychiatry
- Duloxetine in Psychiatric Disorders: Expansions Beyond Major Depression and Generalized Anxiety Disorder
- (2019) Maria Rosaria Anna Muscatello et al. Frontiers in Psychiatry
- Depressive Symptoms, Antidepressant Use, and Hypertension in Young Adulthood
- (2018) Danielle M. Crookes et al. EPIDEMIOLOGY
- Systolic blood pressure as a potential target of sigma-1 receptor agonist therapy
- (2018) Jordana B. Cohen et al. Journal of Clinical Hypertension
- Antidepressant use during pregnancy and the risk of developing gestational hypertension: a retrospective cohort study
- (2018) Neily Zakiyah et al. BMC Pregnancy and Childbirth
- Myocardial Injury from Tranylcypromine-Induced Hypertensive Crisis Secondary to Excessive Tyramine Intake
- (2018) Mark Salter et al. Cardiovascular Toxicology
- Effects of SSRI medication on heart rate and blood pressure in individuals with hypertension and depression
- (2018) MF Peixoto et al. CLINICAL AND EXPERIMENTAL HYPERTENSION
- 2018 ESC Guidelines for the diagnosis and management of syncope
- (2018) Michele Brignole et al. Kardiologia Polska
- Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017
- (2018) Spencer L James et al. LANCET
- Adverse effects of interactions between antidepressants and medications used in treatment of cardiovascular disorders.
- (2018) Jarosław Woroń et al. Psychiatria Polska
- Tranylcypromine in mind (Part I): Review of pharmacology
- (2017) Sven Ulrich et al. EUROPEAN NEUROPSYCHOPHARMACOLOGY
- Dopamine System Dysregulation in Major Depressive Disorders
- (2017) Pauline Belujon et al. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY
- Effects of psychopharmacological treatment with antidepressants on the vascular system
- (2017) Kai G. Kahl et al. VASCULAR PHARMACOLOGY
- Initiation of β-blocker therapy and depression after acute myocardial infarction
- (2016) Anil M. Ranchord et al. AMERICAN HEART JOURNAL
- Physical Exercise for Late-Life Depression: Effects on Heart Rate Variability
- (2016) Giulio Toni et al. AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY
- The Role of Levomilnacipran in the Management of Major Depressive Disorder: A Comprehensive Review
- (2016) Antonio Bruno et al. Current Neuropharmacology
- The Preclinical and Clinical Effects of Vilazodone for the Treatment of Major Depressive Disorder
- (2016) Zeyad T. Sahli et al. Expert Opinion on Drug Discovery
- Vortioxetine: a New Treatment for Major Depressive Disorder
- (2016) K. Ryan Connolly et al. EXPERT OPINION ON PHARMACOTHERAPY
- The safety and tolerability of vortioxetine: Analysis of data from randomized placebo-controlled trials and open-label extension studies
- (2016) David S Baldwin et al. JOURNAL OF PSYCHOPHARMACOLOGY
- Dysregulation of the dopamine system in the pathophysiology of schizophrenia and depression
- (2016) Anthony A. Grace NATURE REVIEWS NEUROSCIENCE
- Treatment of Depression in Patients with Concomitant Cardiac Disease
- (2016) Robyn M. Teply et al. PROGRESS IN CARDIOVASCULAR DISEASES
- The Safety, Tolerability and Risks Associated with the Use of Newer Generation Antidepressant Drugs: A Critical Review of the Literature
- (2016) André F. Carvalho et al. PSYCHOTHERAPY AND PSYCHOSOMATICS
- Major Depressive Disorder and Bipolar Disorder Predispose Youth to Accelerated Atherosclerosis and Early Cardiovascular Disease
- (2015) Benjamin I. Goldstein et al. CIRCULATION
- Multiple system atrophy: Using clinical pharmacology to reveal pathophysiology
- (2015) Jens Jordan et al. CLINICAL AUTONOMIC RESEARCH
- Role of Peripheral Vascular Resistance for the Association Between Major Depression and Cardiovascular Disease
- (2015) Elena V. Bouzinova et al. JOURNAL OF CARDIOVASCULAR PHARMACOLOGY
- Antidepressant medication can improve hypertension in elderly patients with depression
- (2015) Wenjing Fu et al. JOURNAL OF CLINICAL NEUROSCIENCE
- Activation of sigma-1 receptor chaperone in the treatment of neuropsychiatric diseases and its clinical implication
- (2015) Kenji Hashimoto JOURNAL OF PHARMACOLOGICAL SCIENCES
- Evidence-based guidelines for treating depressive disorders with antidepressants: A revision of the 2008 British Association for Psychopharmacology guidelines
- (2015) Anthony Cleare et al. JOURNAL OF PSYCHOPHARMACOLOGY
- Autonomic dysfunction and heart rate variability in depression
- (2015) Andrea Sgoifo et al. STRESS-THE INTERNATIONAL JOURNAL ON THE BIOLOGY OF STRESS
- Efficacy and Tolerability of Generic Mirtazapine (Mirtax) for Major Depressive Disorder: Multicenter, Open-label, Uncontrolled, Prospective Study
- (2015) Hoo Rim Song et al. Clinical Psychopharmacology and Neuroscience
- Venlafaxine as single therapy associated with hypertensive encephalopathy
- (2015) Bengt Edvardsson SpringerPlus
- Cardiovascular Adverse Reactions During Antidepressant Treatment: A Drug Surveillance Report of German-Speaking Countries Between 1993 and 2010
- (2015) C. J. Spindelegger et al. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY
- A Comparison of the Risk of QT Prolongation Among SSRIs
- (2014) Kylee A. Funk et al. ANNALS OF PHARMACOTHERAPY
- Depression as a Risk Factor for Poor Prognosis Among Patients With Acute Coronary Syndrome: Systematic Review and Recommendations
- (2014) Judith H. Lichtman et al. CIRCULATION
- Safety and Tolerability of Desvenlafaxine in Children and Adolescents with Major Depressive Disorder
- (2014) Robert L. Findling et al. JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY
- Mental health: A world of depression
- (2014) Kerri Smith NATURE
- Acute and Long-term Treatment of Late-Life Major Depressive Disorder: Duloxetine Versus Placebo
- (2013) Michael Robinson et al. AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY
- Safety and Tolerability of Levomilnacipran ER in Major Depressive Disorder: Results from an Open-Label, 48-Week Extension Study
- (2013) Rajnish Mago et al. CLINICAL DRUG INVESTIGATION
- Milnacipran effects on 24-hour ambulatory blood pressure and heart rate in fibromyalgia patients: a randomized, placebo-controlled, dose-escalation study
- (2013) Joel M. Trugman et al. CURRENT MEDICAL RESEARCH AND OPINION
- The cardiovascular safety profile of escitalopram
- (2013) Michael E. Thase et al. EUROPEAN NEUROPSYCHOPHARMACOLOGY
- Efficacy and Safety of Levomilnacipran Sustained Release 40 mg, 80 mg, or 120 mg in Major Depressive Disorder
- (2013) Gregory M. Asnis et al. JOURNAL OF CLINICAL PSYCHIATRY
- A Phase III, Double-Blind, Placebo-Controlled, Flexible-Dose Study of Levomilnacipran Extended-Release in Patients With Major Depressive Disorder
- (2013) Angelo Sambunaris et al. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY
- Alcohol and psychotropic drugs: risk factors for orthostatic hypotension in elderly fallers
- (2013) C Gaxatte et al. JOURNAL OF HUMAN HYPERTENSION
- Desvenlafaxine-Induced Worsening of Hypertension
- (2013) Ravindra Neelakanthappa Munoli et al. JOURNAL OF NEUROPSYCHIATRY AND CLINICAL NEUROSCIENCES
- Levomilnacipran (F2695), a norepinephrine-preferring SNRI: Profile in vitro and in models of depression and anxiety
- (2013) A.L. Auclair et al. NEUROPHARMACOLOGY
- Relationship between SSRIs and Metabolic Syndrome Abnormalities in Patients with Generalized Anxiety Disorder: A Prospective Study
- (2013) Murat Beyazyüz et al. Psychiatry Investigation
- Effect of Paroxetine on Physiological Response to Stress and Smoking
- (2013) Michael Kotlyar et al. PSYCHOSOMATIC MEDICINE
- Rediscovering Trazodone for the Treatment of Major Depressive Disorder
- (2012) Andrea Fagiolini et al. CNS DRUGS
- Depression increases the risk of hypertension incidence
- (2012) Lin Meng et al. JOURNAL OF HYPERTENSION
- Depression Treatment Selectively Modifies Arterial Stiffness in Older Participants
- (2012) A. Scuteri et al. JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL SCIENCES
- Improved preclinical cardiovascular therapeutic indices with long-term inhibition of norepinephrine reuptake using reboxetine
- (2012) Anthony A. Fossa et al. TOXICOLOGY AND APPLIED PHARMACOLOGY
- Bupropion for Smoking Cessation in Patients With Acute Coronary Syndrome
- (2011) David Planer et al. ARCHIVES OF INTERNAL MEDICINE
- Vilazodone
- (2011) James E. Frampton CNS DRUGS
- Clinically Significant Drug Interactions with Newer Antidepressants
- (2011) Edoardo Spina et al. CNS DRUGS
- Effects of Paroxetine on the Pharmacokinetics and Pharmacodynamics of Immediate-Release and Extended-Release Metoprolol
- (2011) Robert B Parker et al. PHARMACOTHERAPY
- The importance of norepinephrine in depression
- (2011) Mike Briley et al. Neuropsychiatric Disease and Treatment
- New Drug Approvals: Milnacipran for Treatment of Fibromyalgia
- (2010) Jeffrey A Kyle et al. ANNALS OF PHARMACOTHERAPY
- The effect of a 4-week treatment with reboxetine on metabolic parameters of depressed inpatients
- (2010) Georgios Paslakis et al. EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE
- Broken heart syndrome: Tako Tsubo cardiomyopathy associated with an overdose of the serotonin–norepinephrine reuptake inhibitor Venlafaxine
- (2010) Marian Christoph et al. EUROPEAN NEUROPSYCHOPHARMACOLOGY
- Baseline Depressive Symptoms Are Not Associated With Clinically Important Levels of Incident Hypertension During Two Years of Follow-Up
- (2010) Joseph A.C. Delaney et al. HYPERTENSION
- Influence of Metoprolol Dosage Release Formulation on the Pharmacokinetic Drug Interaction With Paroxetine
- (2010) Stephen M. Stout et al. JOURNAL OF CLINICAL PHARMACOLOGY
- The combined influence of hypertension and common mental disorder on all-cause and cardiovascular disease mortality
- (2010) Mark Hamer et al. JOURNAL OF HYPERTENSION
- Selective Serotonin Reuptake Inhibitor Use and Risk of Gestational Hypertension
- (2009) Sengwee Toh et al. AMERICAN JOURNAL OF PSYCHIATRY
- Interactions between antidepressants and antihypertensive and glucose lowering drugs among patients in the HIPERDIA Program, Coronel Fabriciano, Minas Gerais State, Brazil
- (2009) Paula Vieira Coelho et al. Cadernos de Saude Publica
- Milnacipran
- (2009) Chi-Un Pae et al. CLINICAL NEUROPHARMACOLOGY
- Antidepressants and Falls in the Elderly
- (2009) Adam Darowski et al. DRUGS & AGING
- Depression and Blood Pressure Control: All Antidepressants Are not the Same
- (2009) Tye Dawood et al. HYPERTENSION
- Depression Is Associated With Decreased Blood Pressure, but Antidepressant Use Increases the Risk for Hypertension
- (2009) Carmilla M.M. Licht et al. HYPERTENSION
- Safety and Tolerability of Duloxetine at 60 mg Once Daily in Elderly Patients With Major Depressive Disorder
- (2009) Joel Raskin et al. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY
- Double-blind, placebo-controlled evaluation of extended-release bupropion in elderly patients with major depressive disorder
- (2009) K. Hewett et al. JOURNAL OF PSYCHOPHARMACOLOGY
- Major Depression as a Risk Factor for High Blood Pressure: Epidemiologic Evidence From a National Longitudinal Study
- (2009) Scott B. Patten et al. PSYCHOSOMATIC MEDICINE
- Antidepressant drugs and cardiovascular pathology: a clinical overview of effectiveness and safety
- (2008) D. Taylor ACTA PSYCHIATRICA SCANDINAVICA
- Intima-media thickness and age of first depressive episode
- (2008) Patrick J. Smith et al. BIOLOGICAL PSYCHOLOGY
- Efficacy, safety, and tolerability of desvenlafaxine 50 mg/day and 100 mg/day in outpatients with major depressive disorder
- (2008) Michael R. Liebowitz et al. CURRENT MEDICAL RESEARCH AND OPINION
- A Randomized, Double-Blind, Placebo-Controlled Study of the Effect of Sustained-Release Bupropion on Blood Pressure in Individuals With Mild Untreated Hypertension
- (2008) Michael E. Thase et al. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY
- Hypotension caused by therapeutic doses of venlafaxine: case report and proposed pathophysiological mechanisms
- (2008) Clóvis Alexandrino-Silva et al. JOURNAL OF PSYCHOPHARMACOLOGY
- Serotonin: a review
- (2008) L. F. MOHAMMAD-ZADEH et al. JOURNAL OF VETERINARY PHARMACOLOGY AND THERAPEUTICS
- The selegiline transdermal system in major depressive disorder: A systematic review of safety and tolerability
- (2007) Donald S. Robinson et al. JOURNAL OF AFFECTIVE DISORDERS
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search